Walker & Dunlop CEO reports 61.279 new dividend equivalent rights

Walker & Dunlop Chairman and CEO files insider equity update The Chairman and CEO of Walker & Dunlop, Inc. (WD), who also serves as a director, reported an equity-related transaction dated 12/05/2025.

Rhea-AI Filing Summary

Walker & Dunlop Chairman and CEO files insider equity update

The Chairman and CEO of Walker & Dunlop, Inc. (WD), who also serves as a director, reported an equity-related transaction dated 12/05/2025. The filing shows an acquisition of 61.279 dividend equivalent rights, which are derivatives tied to the company’s common stock.

Each dividend equivalent right is the economic equivalent of one share of Walker & Dunlop common stock and accrued on restricted stock units already held by the executive. These rights vest proportionately with the related restricted stock units, at an exercise price of $0. Following this transaction, the executive directly beneficially owns 461.4314 derivative securities in the form of dividend equivalent rights linked to common shares.

Insider Trade Summary

Grant/Award: 61.279 shares

Grant/Award 1 txn

Insider Walker William M

Role Chairman & CEO

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights	61.279	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 461.4314 contracts (Direct)

Footnotes (2)

1. F1. Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.
2. F2. The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Walker & Dunlop (WD) report in this filing?

The filing reports that the Chairman and CEO of Walker & Dunlop, Inc. acquired 61.279 dividend equivalent rights linked to the company’s common stock on 12/05/2025.

Who is the reporting person in this Walker & Dunlop (WD) insider filing and what is their role?

The reporting person is a director and officer of Walker & Dunlop, serving as Chairman & CEO, and files individually as one reporting person.

What are the dividend equivalent rights reported by Walker & Dunlop (WD)?

Each dividend equivalent right is the economic equivalent of one share of Walker & Dunlop common stock and accrued on restricted stock units held by the executive.

How do the dividend equivalent rights for Walker & Dunlop (WD) vest?

The filing states that the dividend equivalent rights vest proportionately with the restricted stock units to which they relate, following the same vesting schedule.

What is the exercise price for the Walker & Dunlop (WD) dividend equivalent rights?

The dividend equivalent rights reported have an exercise price of $0, reflecting that they accrue as part of existing restricted stock unit awards rather than being purchased for cash.

How many derivative securities does the Walker & Dunlop (WD) executive own after this transaction?

After the 61.279 dividend equivalent rights were acquired, the executive directly beneficially owns 461.4314 derivative securities in the form of dividend equivalent rights tied to common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/09/2025 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Walker William M

(Last) (First) (Middle)

C/O WALKER & DUNLOP, INC.

7272 WISCONSIN AVENUE, SUITE 1300

(Street)

BETHESDA MD 20814

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Walker & Dunlop, Inc. [ WD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/05/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	12/05/2025		A		61.279		(2)	(2)	Common Stock	61.279	$0	461.4314	D

Explanation of Responses:

1. Each dividend equivalent right is the economic equivalent of one share of common stock of the Company.

2. The dividend equivalent rights accrued on restricted stock units held by the reporting person and vest proportionately with the restricted stock units to which they relate.

	/s/ Nicholas C. Eckstein Attorney-in-fact	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.